logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
C

Carlos M. Galmarini

d department

45H-index
319Paper Count
1.0WCitation Count
Published Papers 109
Publication Date
logo
PROCC: a predictive score to identify KRAS wild type metastatic colorectal cancer patients who are likely to obtain survival benefit from panitumumab treatment
errBritish Journal of Cancer
IF6.8
err2025-08-20
err0
PREAI
errCarlos María Galmarini; Rafael Zamora; Pablo Gómez del Campo; José del Castillo-Izquierdo; José Antonio De All; Juan Manuel Domínguez
errShare
errSave
Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19
errCOMPUTERS IN BIOLOGY AND MEDICINE
IF6.3
err2022-10-01
err2
errOAAI
errdeAndres-Galiana, Enrique J.; Luis Fernandez-Martinez, Juan; Alvarez-Machancoses, Oscar; Bea, Guillermina; Galmarini, Carlos M.; Kloczkowski, Andrzej
errShare
errSave
Editorial: Ageing and Carcinogenesis
errFRONTIERS IN ONCOLOGY
IF3.3
err2022-02-16
err0
errOAAI
errRuggiero, Raul A.; Chiarella, Paula; Galmarini, Carlos Maria
errShare
errSave
Detecting panitumumab/FOLFOX responders in K-Ras wildtype metastatic colorectal cancer through an artificial intelligence-based analytical tool
errANNALS OF ONCOLOGY
IF65.4
err2021-07-01
err0
errOAAI
errGalmarini, C.; Lucius, M.
errShare
errSave
Deep Neural Frameworks Improve the Accuracy of General Practitioners in the Classification of Pigmented Skin Lesions
errDIAGNOSTICS
IF3.3
err2020-11-18
err23
errOAAI
errLucius, Maximiliano; De All, Jorge; De All, Jose Antonio; Belvisi, Martin; Radizza, Luciana; Lanfranconi, Marisa; Lorenzatti, Victoria; Galmarini, Carlos M.
errShare
errSave
WHY WE DO WHAT WE DO. A BRIEF ANALYSIS OF CANCER THERAPIES
errEXCLI JOURNAL
IF4.9
err2020-01-01
err7
PREAI
errGalmarini, Carlos M.
errShare
errSave
The Antitumor Drugs Trabectedin and Lurbinectedin Induce Transcription-Dependent Replication Stress and Genome Instability
errMOLECULAR CANCER RESEARCH
IF4.7
err2019-03-01
err31
errOAAI
errTumini, Emanuela; Herrera-Moyano, Emilia; San Martin-Alonso, Marta; Barroso, Sonia; Galmarini, Carlos M.; Aguilera, Andres
errShare
errSave
Re-Education of Tumor Associated Macrophages by Trabectedin
errBIOPHYSICAL JOURNAL
IF3.1
err2019-02-01
err2
errOAAI
errPeraza, Diego A.; Garcia-Redondo, Ana B.; Povo-Retana, Adrian; Arias, Sara; Briones, Ana M.; Bosca, Lisardo; Galmarini, Carlos M.; Valenzuela, Carmen
errShare
errSave
Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival
errBRITISH JOURNAL OF CANCER
IF6.8
err2018-11-13
err34
errOAAI
errLosada, Alejandro; Jose Munoz-Alonso, Maria; Martinez-Diez, Marta; Gago, Federico; Manuel Dominguez, Juan; Fernando Martinez-Leal, Juan; Galmarini, Carlos M.
errShare
errSave
ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line
errFUTURE ONCOLOGY
IF2.6
err2018-10-26
err71
errOAAI
errFarago, Anna F.; Drapkin, Benjamin J.; Antonio Lopez-Vilarino de Ramos, Jose; Galmarini, Carlos M.; Nunez, Rafael; Kahatt, Carmen; Paz-Ares, Luis
errShare
errSave
Plocabulin, a tubulin inhibitor, presents antitumor activity in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST)
errCANCER RESEARCH
IF16.6
err2018-07-01
err0
PREAI
errWozniak, Agnieszka; Wang, Yannick; Wellens, Jasmien; Gebreyohannes, Yemarshet K.; Jose Guillen, Maria; Galmarini, Carlos M.; Aviles, Pablo M.; Debiec-Rychter, Maria; Sciot, Raf; Schoffski, Patrick
errShare
errSave
eEF1A2 interacts with and inhibits PKR to enhance cancer cell survival
errCANCER RESEARCH
IF16.6
err2018-07-01
err0
PREAI
errMartinez-Leal, Juan F.; Losada, Alejandro; Jose Munoz, Maria; Martinez-Diez, Marta; Manuel Dominguez, Juan; Galmarini, Carlos M.
errShare
errSave
Exploratory testing of PM060184 compound in high-grade serous ovarian carcinoma cell lines
errCANCER RESEARCH
IF16.6
err2018-07-01
err0
PREAI
errHeredia-Soto, Victoria; Redondo, Andres; Gallego, Alejandro; Miguel-Martin, Maria; Crespo, Roberto; Hernandez, Alicia; Hardisson, David; Feliu, Jaime; Galmarini, Carlos; Mendiola, Marta
errShare
errSave
Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin
errSCIENTIFIC REPORTS
IF3.9
err2018-06-05
err13
errOAAI
errPantazopoulou, Areti; Maria Galmarini, Carlos; Penalva, Miguel A.
errShare
errSave
MI130004, a Novel Antibody-Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors
errMOLECULAR CANCER THERAPEUTICS
IF5.5
err2018-04-01
err19
errOAAI
errAviles, Pablo; Manuel Dominguez, Juan; Jose Guillen, Maria; Jose Munoz-Alonso, Maria; Mateo, Cristina; Rodriguez-Acebes, Raquel; Manuel Molina-Guijarro, Jose; Francesch, Andres; Fernando Martinez-Leal, Juan; Munt, Simon; Galmarini, Carlos M.; Cuevas, Carmen
errShare
errSave
Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells
errBMC CANCER
IF3.4
err2018-02-07
err30
errOAAI
errGalmarini, Carlos M.; Martin, Maud; Bouchet, Benjamin Pierre; Guillen-Navarro, Maria Jose; Martinez-Diez, Marta; Martinez-Leal, Juan Fernando; Akhmanova, Anna; Aviles, Pablo
errShare
errSave
Dynamic cellular maps of molecular species: Application to drug-target interactions
errSCIENTIFIC REPORTS
IF3.9
err2018-01-18
err5
errOAAI
errGarcia, Carolina; Losada, Alejandro; Sacristan, Miguel A.; Fernando Martinez-Leal, Juan; Galmarini, Carlos M.; Pilar Lillo, M.
errShare
errSave
Plitidepsin inhibits autophagy, the main mechanism of acquired resistance to bortezomib
errMOLECULAR CANCER THERAPEUTICS
IF5.5
err2018-01-01
err0
PREAI
errMartinez-Leal, Juan F.; Quiniou, Gaelle; Losada, Alejandro; Jose Munoz, Maria; Sanchez-Mesa, Rafael; Martinez-Rivas, Patricia; Manuel Dominguez, Juan; Galmarini, Carlos M.
errShare
errSave
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
errBRITISH JOURNAL OF CANCER
IF6.8
err2017-07-06
err130
errOAAI
errBelgiovine, Cristina; Bello, Ezia; Liguori, Manuela; Craparotta, Ilaria; Mannarino, Laura; Paracchini, Lara; Beltrame, Luca; Marchini, Sergio; Galmarini, Carlos M.; Mantovani, Alberto; Frapolli, Roberta; Allavena, Paola; D'Incalci, Maurizio
errShare
errSave
Plitidepsin targets the moonlighting functions of eEF1A2 in cancer cells
errCANCER RESEARCH
IF16.6
err2017-07-01
err0
PREAI
errLosada, Alejandro; Munoz, Maria Jose; Martinez-Leal, Juan F.; Dominguez, Juan M.; Galmarini, Carlos M.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
José Baselga
H-index: 143 · Papers: 1.4K
F
Franco Locatelli
H-index: 125 · Papers: 2.1K
A
Alessandro Rambaldi
H-index: 125 · Papers: 1.5K
A
Andrea Biondi
H-index: 118 · Papers: 1.2K
M
Mario Cazzola
H-index: 117 · Papers: 817
View more